Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Entera Bio Ltd (ENTX)

Entera Bio Ltd (ENTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Entera Bio Ltd KIRYAT HADASSAH MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 ISR

www.enterabio.com Employees: 20 P: 972-2532-7151

Sector:

Medical

Description:

Entera Bio Ltd. is a clinical-stage biopharmaceutical company. It focused on the development and commercialization of orally delivered molecule therapeutics for use in orphan indications and other areas with significant unmet medical need. The Company is initially applying its technology to develop an oral formulation of parathyroid hormone for hypoparathyroidism and osteoporosis. Entera Bio Ltd. is based in Jerusalem, Israel.

Key Statistics

Overview:

Market Capitalization, $K 97,217
Enterprise Value, $K 88,557
Shares Outstanding, K 45,857
Annual Sales, $ 180 K
Annual Net Income, $ -9,540 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -2,660 K
EBIT, $ -10,590 K
EBITDA, $ -10,540 K
60-Month Beta 1.71
% of Insider Shareholders 10.38%
% of Institutional Shareholders 14.11%
Float, K 41,097
% Float 89.62%
Short Volume Ratio 0.09

Growth:

1-Year Return -7.42%
3-Year Return 217.37%
5-Year Return 100.00%
5-Year Revenue Growth -25.00%
5-Year Earnings Growth 71.91%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.07 on 11/14/25
Next Earnings Date 03/27/26
Earnings Per Share ttm -0.26
EPS Growth vs. Prev Qtr -16.67%
EPS Growth vs. Prev Year 12.50%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

ENTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -67.56%
Return-on-Assets % -59.50%
Profit Margin % -5,300.00%
Debt/Equity 0.00
Price/Sales 524.44
Price/Cash Flow N/A
Price/Book 6.38
Book Value/Share 0.38
Interest Coverage -0.87
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar